4Cuningham RT, Watt M, Winder J, et al. Serum neuron specificas enolase as a indicator of stroke volume. Eur J Clin Invest, 1996, 26(4): 298-303.
5Degiorgio CM, Correale JD, Ginsburg DL, et al. Serum neuron specific enolase in human status epileptics. Epilepsia, 1994,44(suppl 2) : 205-208.
6Person L, Hardmark HG, Gustafasson J, et al. S-100 and neuron-specific enolase in cerebrspinal fluid and serum: markers of cell damage in human central nervous system, stroke, 1987,18:911-918.
7Herrmann M, Jost S, Kutz S, et al, Temporal profile of release of nenrobiochemical markera of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomogryaphy[J]. J Neurotrauma ,2000,17(2): 113-122.
8Newcomb JK, Zhao X, Pike BR, et al, Temporal profile of apoptotic-like changes in neurons and astrocytes following controlled cortical impact injury in the rat[J]. Exp Neurol, 1999, 158(1):76-88.
9Raabe A, Seifert V. Fatal secondary increase in serum s-100 protein after severe head injury[J]. J Neurosurg, 1999,91(5):875-877.
3Michetti F, Gazzolo D. S100B protein in biological fluids: a tool for perinatal medicine[J]. Clin Chem, 2002,48(12):2097-2104.
4Gazzolo D, Bruschettini M, Lituania M,el al. S100B protein concentrations in urine are correlated with gestational age in healthy preterm and term newborns[J]. Clin Chem, 2001,47(6): 1132-1133.
